Ghent University Academic Bibliography

Your filters: cql: author="Bourdin, A" or (type any "bookEditor issueEditor" and editor="Bourdin, A")

Add to list
- Journal Article
- A1
- open access
Modélisation de l’asthme sévère par la technologie des cellules humaines souches pluripotentes induites (hiPSC)

Engi Ahmed (UGent) , S Assou, F Foisset, C Bourdais, Manon Vanheerswynghels (UGent) , A Petit, A S Gamez, D Gras, P Chanez, J de Vos, et al.

(2024) REVUE DES MALADIES RESPIRATOIRES. 41(4). p.289-293
Add to list
- Journal Article
- A1
- open access
Phenotyping of severe asthma in the era of broad-acting anti-asthma biologics

A Bourdin, Guy Brusselle (UGent) , S Couillard, ML Fajt, LG Heaney, E Israel, PJ McDowell, A Menzies-Gow, N Martin, PD Mitchell, et al.

(2024) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 12(4). p.809-823
Add to list
- Journal Article
- A1
- open access
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease

Yannick Allanore, Dinesh Khanna, Vanessa Smith (UGent) , Martin Aringer, Anna-Maria Hoffmann-Vold, Masataka Kuwana, Peter A Merkel, Christian Stock, Steven Sambevski, Christopher P Denton, et al.

(2024) RHEUMATOLOGY. 63(3). p.639-647
Add to list
- Conference Paper
- C3
Liberty asthma traverse dupilumab shows sustained efficacy and improvements in asthma control and health-related quality of life (HRQOL) in patients with moderate-to-severe asthma

M Wechsler, LB Ford, JF Maspero, ID Pavord, D Langton, C Domingo, A Papi, A Bourdin, H Watz, X. Mao, et al.

(2021) VALUE IN HEALTH. In Value in Health 24(Supplement 1). p.S14-S14
Add to list
- Conference Paper
- C3
Dupilumab shows sustained efficacy and improvements in asthma control and health-related quality of life in patients with moderate-to-severe asthma : liberty asthma traverse

M Wechsler, LB Ford, JF Maspero, ID Pavord, D Langton, C Domingo, A Papi, A Bourdin, H Watz, X. Mao, et al.

(2021) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. In American Journal of Respiratory and Critical Care Medicine 203(9S). p.A1452-A1452
Add to list
- Conference Paper
- C3
Long-term efficacy of dupilumab in patients with moderate-to-severe asthma in the liberty asthma traverse open-label extension study : improvements in asthma control and health-related quality of life

ID Pavord, ME Wechsler, LB Ford, JF Maspero, D Langton, C Domingo, A Papi, A Bourdin, H Watz, X. Mao, et al.

(2021) THORAX. In Thorax 76(Supplement 2). p.A91-A92
Add to list
Integrated care pathways for airway diseases (AIRWAYS-ICPs)

J Bousquet, A Addis, I Adcock, I Agaché, A Agusti, A Alonso, I Annesi-Maesano, JM Anto, Claus Bachert (UGent) , CE Baena-Cagnani, et al.

(2014) EUROPEAN RESPIRATORY JOURNAL. 44(2). p.304-323

Academic Bibliography

Modélisation de l’asthme sévère par la technologie des cellules humaines souches pluripotentes induites (hiPSC)

Phenotyping of severe asthma in the era of broad-acting anti-asthma biologics

Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease

Liberty asthma traverse dupilumab shows sustained efficacy and improvements in asthma control and health-related quality of life (HRQOL) in patients with moderate-to-severe asthma

Dupilumab shows sustained efficacy and improvements in asthma control and health-related quality of life in patients with moderate-to-severe asthma : liberty asthma traverse

Long-term efficacy of dupilumab in patients with moderate-to-severe asthma in the liberty asthma traverse open-label extension study : improvements in asthma control and health-related quality of life

Integrated care pathways for airway diseases (AIRWAYS-ICPs)

Contents

Support

Contact